Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Immuneed AB
AB
Active
Org 5569744807
Kungsgatan 70 D, 753 41
Uppsala
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2014 · 12 years old
10-19 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Immuneed AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
6M
13M
19M
25M
10M
2020
13M
2021
22M
2022
20M
2023
12M
2024
EBITDA
SEK millions
0M
-3M
-6M
-8M
-11M
-3M
2020
-6M
-100%
2021
-7M
-17%
2022
-9M
-29%
2023
-8M
+11%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
9 834
12 957
22 149
19 902
12 186
Staff expenses
—
—
—
—
—
EBITDA
−3 056
−5 584
−7 058
−8 831
−7 781
Depreciation & amort.
−257
−310
−417
−387
−332
EBIT
−3 313
−5 894
−7 475
−9 218
−8 113
Net financials
−61
−44
−54
−138
−146
Profit before tax
−3 374
−5 938
−7 530
−9 356
−8 259
Tax
−0
−0
−0
−0
−0
Net profit
−3 374
−5 938
−7 530
−9 356
−8 259
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
5 171
10 842
11 002
13 840
9 852
Equity
1 971
3 689
2 597
5 056
4 538
Long-term debt
0
813
903
924
479
Short-term debt
3 200
6 340
7 503
7 861
4 835
Total debt
3 200
7 153
8 406
8 785
5 314
Financial ratios
5-year trend
EBITDA-margin
-63.9%
This company
15.8%
Market median
-504% vs market
2020
2024
Soliditetsgrad
46.1%
This company
38.2%
Market median
+21% vs market
2020
2024
Egenkapitalforrentning
-182.0%
This company
18.4%
Market median
-1089% vs market
2020
2024
Nettoresultatgrad
-67.8%
This company
8.1%
Market median
-937% vs market
2020
2024
Aktivomsætning
1.24×
This company
1.12×
Market median
+11% vs market
2020
2024
Gæld/egenkapital
1.17×
This company
0.62×
Market median
-89% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Immuneed AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
